Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
NCT03202303
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This trial aims to study the efficacy and safety of cannabidivarin (CBDV) in children with ASD.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Autism Spectrum Disorder
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 5 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Montefiore Medical Center
- Last updated on ClinicalTrials.gov
- October 22, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Montefiore Medical Center · The Bronx, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.